Seelos Therapeutics Inc Sustainability Reports
Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system disorders and rare diseases. Its portfolio includes treatments targeting conditions such as major depressive disorder, post-traumatic stress disorder, and amyotrophic lateral sclerosis.
Sector: Manufacturing
Country: United States
Exchange: OTC Markets
LEI: 5493009HV8O6R1WGZ132
FIGI: BBG001S7J019
1 reports from 2018 to 2018